Evidence map›Paper›PMID 40407074›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Regional variability of the impact of cardiometabolic diseases on incident dementia in United States Medicare beneficiaries.

George K Karway, Brittany Krzyzanowski, Jordan A Killion, Irene M Faust, Osvaldo J Laurido-Soto, Marwan N Sabbagh, Brad A Racette

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Enhancing uptake of antidiabetic drugs to reduce cardiometabolic risk and dementia burden.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  4. Article
  5. The cardiometabolic "bottleneck" on cognitive function in aging.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

George K KarwayDepartment of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.ORCID 0000-0003-4375-6126
Brittany KrzyzanowskiDepartment of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.ORCID 0000-0002-4774-6120
Jordan A KillionDepartment of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.ORCID 0000-0003-3155-1107
Irene M FaustDepartment of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.ORCID 0000-0003-2653-672X
Osvaldo J Laurido-SotoDepartment of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA.
Marwan N SabbaghDepartment of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.
Brad A RacetteDepartment of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.ORCID 0000-0002-9582-8235

Funding

Barrow Neurological FoundationKemper and Ethel Marley FoundationMoreno Family
6 · The paper itself

Abstract

introductionUnderstanding the impact of cardiometabolic diseases (CMDs) on dementia risk can inform primary preventative measures.

methodsWe leveraged a nationwide, population-based Medicare dataset of 20,789,037 beneficiaries (756,321 with incident dementia and 20,032,716 controls) from 2017 to compute the individual and combined population attributable fractions (PAFs) of dementia attributed to eight CMDs, adjusted for age, sex, and race. We mapped PAFs at the county level to investigate the geospatial patterns of CMD burden on dementia across the United States.

resultsThe nationwide combined weighted PAF for the eight CMDs was 37% overall, with hypertension (9.6%), ischemic heart disease (6.7%), and chronic heart failure (5.7%) associated with the greatest attributable fractions of dementia cases. The greatest fraction of county-level dementia cases attributed to CMDs were in the Southeastern United States. DISCUSSION: A substantial proportion of incident dementia cases in the United States can be attributed to CMDs, especially in the Southeastern United States. HIGHLIGHTS: Investigated the combined effect of cardiometabolic diseases (CMDs) on dementia. Used novel geospatial techniques to map the burden of dementia attributed to CMDs. If eight CMDs are mitigated, 37% of incident dementia cases could be eliminated. Identified regions of the United States with high CMD burden on dementia.

Indexed as

Cardiovascular DiseasesDementiaMedicareAgedAged, 80 and overFemaleHumansIncidenceMaleRisk FactorsUnited StatesAlzheimer's diseasecardiometabolic diseasesdementiageographic information systemsgeospatial analysispopulation attributable riskpotential impact fractionrisk factor analysis

Identifiers

PMID40407074
PMCPMC12100501

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.